Published in Br J Clin Pharmacol on August 01, 1981
Bioavailability of labetalol increases with age. Br J Clin Pharmacol (1982) 0.78
Relationship between plasma concentrations and pharmacological effects of labetalol. Eur J Clin Pharmacol (1977) 1.71
Measurement of beta-adrenoceptor antagonists in biological fluids using a radioreceptor assay. Eur J Pharmacol (1978) 1.33
A radioreceptor assay for propranolol. Clin Pharmacol Ther (1979) 0.97
Effect of age and sex on human drug metabolism. Br Med J (1971) 5.19
Management of elderly patients with sustained hypertension. BMJ (1992) 4.92
The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systems. J Hypertens (1990) 3.89
Individual quality of life in patients undergoing hip replacement. Lancet (1992) 3.88
Measurement error in the Hawksley random zero sphygmomanometer: what damage has been done and what can we learn? BMJ (1993) 3.69
Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther (1976) 3.16
Inaccuracy of the Hawksley random zero sphygmomanometer. Lancet (1990) 2.99
Sphygmomanometers in hospital and family practice: problems and recommendations. Br Med J (Clin Res Ed) (1982) 2.83
The clinical pharmacology of mexiletine. Br J Clin Pharmacol (1978) 2.56
Constitutively expressed rat mRNA encoding a 70-kilodalton heat-shock-like protein. Mol Cell Biol (1985) 2.51
Assessing the quality of life of the individual: the SEIQoL with a healthy and a gastroenterology unit population. Psychol Med (1991) 2.46
Pharmacokinetics in the elderly. Clin Pharmacokinet (1976) 2.46
Cardiotoxicity of amitriptyline. Lancet (1972) 2.37
Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet (2001) 2.36
Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol (1995) 2.29
Dippers and non-dippers. Lancet (1988) 2.28
Drug therapy: Management of hypertension in the elderly. N Engl J Med (1980) 2.03
Blood pressure measurement: current practice and future trends. Br Med J (Clin Res Ed) (1985) 1.99
ABC of blood pressure measurement: technique. Br Med J (1979) 1.98
The clinical utility of computed tomographic scanning and neurologic examination in the management of patients with minor head injuries. J Trauma (1992) 1.91
Neuropsychiatric implications and long-term consequences of fetal alcohol spectrum disorders. Semin Clin Neuropsychiatry (2000) 1.84
Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin Pharmacol Ther (1974) 1.81
The need to retrieve the dropped stone during laparoscopic cholecystectomy. Am J Surg (1994) 1.76
Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol (1976) 1.71
Mexiletine (Kö 1173) in the management of ventricular dysrhythmias. Lancet (1973) 1.68
Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study. J Hypertens (1991) 1.66
Clinical pharmacokinetics of oral anticoagulants. Clin Pharmacokinet (1979) 1.66
Determinants of anticoagulant control in patients receiving warfarin. Br J Clin Pharmacol (1977) 1.64
Management of pregnancy in patients with hypertrophic cardiomyopathy. Br Med J (1979) 1.64
Inaccuracy of seven popular sphygmomanometers for home measurement of blood pressure. J Hypertens (1990) 1.64
Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc (1988) 1.60
Drug promotion and the doctor. Br J Clin Pharmacol (1982) 1.58
Training and assessment of observers for blood pressure measurement in hypertension research. J Hum Hypertens (1991) 1.49
Plasma digoxin concentrations in patients on admission to hospital. Br Heart J (1974) 1.46
Impairment of human drug metabolism by oral contraceptive steroids. Clin Pharmacol Ther (1972) 1.45
Educational value of printed information for patients with hypertension. Br Med J (Clin Res Ed) (1981) 1.42
A within-patient comparison of debrisoquine and methyldopa in hypertension. Br Med J (1971) 1.42
Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society protocol. J Hypertens (1991) 1.42
The quest for better validation: a critical comparison of the AAMI and BHS validation protocols for ambulatory blood pressure measurement systems. Biomed Instrum Technol (1992) 1.39
Pharmacokinetics of enalapril in normal subjects and patients with renal impairment. Br J Clin Pharmacol (1986) 1.38
Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest (1995) 1.37
Where are the guidelines for treating hypertension in elderly patients? BMJ (1992) 1.37
Ambulatory blood pressure measurement in general practice. Br J Gen Pract (1992) 1.36
Increased antipyrine half-life in women taking oral contraceptives. Scott Med J (1970) 1.36
Spectrophotofluorometric and gas-liquid chromatographic methods for the estimation of mexiletine (Kö 1173) in plasma and urine. J Pharm Pharmacol (1973) 1.36
Duration of action of beta-blocking drugs. Br Med J (1973) 1.33
Measurement of theophylline in plasma by high performance liquid chromatography. Br J Clin Pharmacol (1976) 1.31
Digoxin in the elderly: pharmacokinetic consequences of old age. Clin Pharmacol Ther (1979) 1.29
Measurement of plasma mexiletine concentrations. Postgrad Med J (1977) 1.28
Accuracy of the Takeda TM-2420/TM-2020 determined by the British Hypertension Society protocol. J Hypertens (1991) 1.26
Individual quality of life in the healthy elderly. Qual Life Res (1994) 1.25
Prescribing for the elderly: Part II. Prescribing patterns: differences due to age. J Am Geriatr Soc (1988) 1.23
Theophylline kinetics in relation to age: the importance of smoking. Br J Clin Pharmacol (1980) 1.23
DRG reimbursement for trauma: the demise of the trauma center (the use of ISS grouping as an early predictor of total hospital cost). J Trauma (1988) 1.21
Selection of the nuclear gene for the mitochondrial adenine nucleotide translocator by genetic complementation of the op1 mutation in yeast. J Biol Chem (1982) 1.20
Inaccuracy of London School of Hygiene sphygmomanometer. Br Med J (Clin Res Ed) (1982) 1.20
Individual variation in the production of a 'bystander signal' following irradiation of primary cultures of normal human urothelium. Carcinogenesis (2001) 1.19
Age and beta adrenoceptor-mediated function. Clin Pharmacol Ther (1980) 1.19
Medical insurance and the use of health care services by the elderly. J Health Econ (1997) 1.18
Drug-metabolizing capacity in states of drug dependence and withdrawal. Br J Pharmacol (1972) 1.17
Compliance with drug treatment. Br Med J (Clin Res Ed) (1981) 1.17
Printed information for the lay public on cardiovascular disease. Br Med J (1980) 1.15
Patients, prescribing, and benzodiazepines. Eur J Clin Pharmacol (1988) 1.15
Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration. Postgrad Med J (1977) 1.13
Adverse drug reactions in the elderly. Br J Hosp Med (1989) 1.11
The development of mexiletine in the management of ventricular dysrhythmias. Postgrad Med J (1977) 1.09
Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity. J Clin Invest (1975) 1.07
Management of high blood pressure in general practice. Ir Med J (1982) 1.07
Do patients take digoxin? Br Heart J (1978) 1.06
Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation. Mol Endocrinol (2000) 1.05
Comparative accuracy of six ambulatory devices according to blood pressure levels. J Hypertens (1993) 1.04
Plasma digoxin levels in infants. Arch Dis Child (1973) 1.02
Overdiagnosing hypertension. BMJ (1988) 1.01
Ecological constraints on mental health services. Am Psychol (1966) 1.00
Twenty-four-hour ambulatory blood pressure measurement in a primigravid population. J Hypertens (1993) 1.00
Cumulative sums in quantifying circadian blood pressure patterns. Hypertension (1992) 0.99
The sphygmomanometer. Br Med J (1979) 0.99
Stimulation of drug metabolism in man by tricyclic antidepressants. Eur J Clin Pharmacol (1973) 0.99
Survey of medication documentation at hospital discharge: implications for patient safety and continuity of care. Ir J Med Sci (2008) 0.99
Beta-adrenoceptor adaptation to acute exercise. J Physiol (1983) 0.98
Clinical and pharmacokinetic properties of a transdermal nicotine patch. Clin Pharmacol Ther (1990) 0.98
Mexiletine in normal volunteers. Br J Clin Pharmacol (1978) 0.97
The excretion of enalapril and enalaprilat in human breast milk. Eur J Clin Pharmacol (1990) 0.97
Home measurement of blood pressure: training of relatives. Ir Med J (1981) 0.96
Accuracy of indirect blood pressure measurement in the elderly. Br Med J (Clin Res Ed) (1983) 0.96
Adrenoceptor function and ageing. Clin Sci (Lond) (1984) 0.95
Changes in human drug metabolism after long-term exposure to hypnotics. Br Med J (1972) 0.95
Hospital mortality of acute myocardial infarction in the thrombolytic era. Heart (1999) 0.95
Evaluation of the SpaceLabs 90202 non-invasive ambulatory recorder according to the AAMI Standard and BHS criteria. J Hum Hypertens (1991) 0.95
Ambulatory blood pressure measurement in the evaluation of blood pressure lowering drugs. J Hypertens (1989) 0.95
ABC of blood pressure measurement. Reconciling the controversies: a comment on "the literature". Br Med J (1979) 0.94
Pharmacokinetics of low-dose methotrexate in children receiving maintenance therapy for acute lymphoblastic leukaemia. Cancer Chemother Pharmacol (1982) 0.94
Structural change in alpha-chymotrypsin induced by complexation with alpha 1-antichymotrypsin as seen by enhanced sensitivity to proteolysis. Biochemistry (1996) 0.94
Massive digoxin overdose: observations on hyperkalaemia and plasma digoxin levels. Scott Med J (1972) 0.93
Duration of hydralazine action in hypertension. Clin Pharmacol Ther (1975) 0.93
Accuracy and reliability of two indirect ambulatory blood pressure recorders: Remler M2000 and Cardiodyne Sphygmolog. Br Heart J (1982) 0.93